drugset / Trial / NCT06313593
A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative Neoplasms
Non-randomizedSequentialOpen-labelTreatment
Summary
This study is being conducted to assess the Safety, Tolerability, and Pharmacokinetics of INCB160058 in Participants With Myeloproliferative Neoplasms.
Timeline
- Start
- 2024-08-08
- Primary completion
- 2028-10-09
- Completion
- 2028-10-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | INCB160058 | Unknown | — | Oral |